Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.

Empowering independent CytoSorb® Therapy

*Not available in the US

 

CE-marked under MDR since 06/2024

Take care of your patients wherever and whenever they need the proven benefits of CytoSorbents’ hemoadsorption therapies.

 

PuriFi is specifically designed for application of CytoSorbents’ hemoadsorption solutions, allowing rapid training and quick and easy setup when needed. Designed with maximum mobility in mind, it can be used in the Emergency Room, in the Intensive Care Unit, or in Intermediate Care settings.

PuriFi attributes

Intuitive touchscreen interface
Maintenance-free pressure monitoring
Pre-assembled adult and pediatric line kit
Auto-leveling bubble catcher
Temperature management option
Rapid set-up in 10min and automated priming

Overcome challenges by using CytoSorb in standalone configurations

Proven safety

Over 250,000 treatments administrated over the last ten years

 

Most peer-reviewed adsorber

Over 1,100 publications, abstracts, poster, manuscripts, and other resources.

Improved patient outcomes

With demonstrated efficacy across cardiovascular, kidney, liver, and critical care.

Contact us to discover more
about PuriFi

PuriFi at a glance

  • Mitzner et al. J Clin Med. 2023;12(23):7199
  • Schmoeckel et al., J Throm & Thrombolysis 2024; epub
  • Doukas et al., J Clin Med 2023; 12:546
  • Haidari et al., ICV&TS 2023; 36(1):ivad010
  • Nemeth et al., ESC Heart Failure 2024; 11(2):772-782
  • Grafe et al., Ren Fail 2023; 45(2):2259231
  • Haselwanter et al., Sci Rep 2024; 14(1):11309
  • Jansen et al., Critical Care 2023; 27(1):117
  • Akil et al., J Clin Med 2022; 11(20):5990
CytoSorbents

Voices around the world

world map
Critical Care
Prof. Olfa Hamzaoui
Reims, France

To be honest with you, we are not using CytoSorb at the moment. And I think that it is just a lack of knowledge about the technique.

Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…

Critical Care
Dr. Daniela Nickoleit-Bitzenberger
Dortmund, Germany

Without CytoSorb, things would have been very dicey. We would probably have had to admit him to a special clinic for liver deseases.